Chen, Yiheng
Lu, Tianyuan http://orcid.org/0000-0002-5664-5698
Pettersson-Kymmer, Ulrika
Stewart, Isobel D.
Butler-Laporte, Guillaume http://orcid.org/0000-0001-5388-0396
Nakanishi, Tomoko http://orcid.org/0000-0001-9510-5646
Cerani, Agustin
Liang, Kevin Y. H.
Yoshiji, Satoshi
Willett, Julian Daniel Sunday
Su, Chen-Yang http://orcid.org/0000-0001-6071-4660
Raina, Parminder
Greenwood, Celia M. T. http://orcid.org/0000-0002-2427-5696
Farjoun, Yossi
Forgetta, Vincenzo
Langenberg, Claudia
Zhou, Sirui
Ohlsson, Claes http://orcid.org/0000-0002-9633-2805
Richards, J. Brent http://orcid.org/0000-0002-3746-9086
Article History
Received: 14 March 2022
Accepted: 18 November 2022
First Online: 12 January 2023
Ethics declarations
: This study was approved by the research ethics boards of the Jewish General Hospital, protocol number 2021–2762.
: J.B.R. has served as an advisor to GlaxoSmithKline and Deerfield Capital. J.B.R.’s institution has received investigator-initiated grant funding from Eli Lilly, GlaxoSmithKline and Biogen for projects unrelated to this research. J.B.R. is the CEO of 5 Prime Sciences (ExternalRef removed). T.L. and V.F. are employees of 5 Prime Sciences. Y.F. consults for Fulcrum Genomics, 5 Prime Sciences, and Demetria. T.N. has received speaking fees from Boehringer Ingelheim and AstraZeneca. All other authors declare that there are no conflicts of interest. The opinions expressed in this manuscript are the authors’ own and do not reflect the views of the Canadian Longitudinal Study on Aging.